VBI Vaccines
VBIV
#10656
Rank
A$2.61 M
Marketcap
A$0.09129
Share price
0.00%
Change (1 day)
-90.45%
Change (1 year)

EPS for VBI Vaccines (VBIV)

EPS in 2024 (TTM): A-$15.27

According to VBI Vaccines 's latest financial reports the company's current EPS (TTM) is A-$14.18. In 2022 the company made an earnings per share (EPS) of A-$18.45 a decrease over its 2021 EPS that were of A-$11.32.

EPS history for VBI Vaccines from 1997 to 2024

Annual EPS

Year EPS Change
2024 (TTM)A-$15.27
2022A-$18.4562.96%
2021A-$11.3228.57%
2020A-$8.81-54.35%
2019A-$19.29-52.58%
2018A-$40.6810.23%
2017A-$36.9114.29%
2016A-$32.29-62.8%
2015A-$86.8290.68%
2014A-$45.53-7.95%
2013A-$49.46-57.97%
2012A-$117.70-78%
2011A-$535.093151.47%
2010A-$16.4623.87%
2009A-$13.29-18.48%
2008A-$16.3012.08%
2007A-$14.54-49.47%
2006A-$28.78
2005N/A-100%
2004A-$12.7911.94%
2003A-$11.43-81.89%
2002A-$63.11196.44%
2001A-$21.2984.33%
2000A-$11.55-65.37%
1999A-$33.35-29.45%
1998A-$47.2729.61%
1997A-$36.47

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Onconova Therapeutics
ONTX
A-$1.33-90.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Curis
CRIS
A-$5.13-63.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Myriad Genetics
MYGN
A-$6.05-57.30%๐Ÿ‡บ๐Ÿ‡ธ USA